Royal Bank of Canada’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.9M | Sell |
|
|||||
|
2025
Q2 | $44.4M | Sell |
|
|||||
|
2025
Q1 | $94.5M | Buy |
|
|||||
|
2024
Q4 | $28.6M | Sell |
|
|||||
|
2024
Q3 | $32.9M | Sell |
|
|||||
|
2024
Q2 | $36.3M | Buy |
|
|||||
|
2024
Q1 | $47M | Sell |
|
|||||
|
2023
Q4 | $43.4M | Sell |
|
|||||
|
2023
Q3 | $37.1M | Buy |
|
|||||
|
2023
Q2 | $39.6M | Buy |
|
|||||
|
2023
Q1 | $34M | Sell |
|
|||||
|
2022
Q4 | $37.3M | Sell |
|
|||||
|
2022
Q3 | $35.8M | Sell |
|
|||||
|
2022
Q2 | $164M | Sell |
|
|||||
|
2022
Q1 | $221M | Buy |
|
|||||
|
2021
Q4 | $273M | Buy |
|
|||||
|
2021
Q3 | $297M | Sell |
|
|||||
|
2021
Q2 | $271M | Buy |
|
|||||
|
2021
Q1 | $209M | Buy |
|
|||||
|
2020
Q4 | $171M | Buy |
|
|||||
|
2020
Q3 | $152M | Buy |
|
|||||
|
2020
Q2 | $100M | Buy |
|
|||||
|
2020
Q1 | $67.9M | Sell |
|
|||||
|
2019
Q4 | $88.4M | Buy |
|
|||||
|
2019
Q3 | $71.9M | Buy |
|
|||||
|
2019
Q2 | $53.7M | Buy |
|
|||||
|
2019
Q1 | $48M | Sell |
|
|||||
|
2018
Q4 | $37.6M | Sell |
|
|||||
|
2018
Q3 | $48M | Sell |
|
|||||
|
2018
Q2 | $44.2M | Buy |
|
|||||
|
2018
Q1 | $41.7M | Buy |
|
|||||
|
2017
Q4 | $41.9M | Sell |
|
|||||
|
2017
Q3 | $44.3M | Buy |
|
|||||
|
2017
Q2 | $40.8M | Buy |
|
|||||
|
2017
Q1 | $36.2M | Sell |
|
|||||
|
2016
Q4 | $31.1M | Sell |
|
|||||
|
2016
Q3 | $34.4M | Sell |
|
|||||
|
2016
Q2 | $34.6M | Buy |
|
|||||
|
2016
Q1 | $31.2M | Sell |
|
|||||
|
2015
Q4 | $37M | Buy |
|
|||||
|
2015
Q3 | $2.25M | Buy |
|
|||||
|
2015
Q2 | $2.29M | Buy |
|
|||||
|
2015
Q1 | $2.38M | Buy |
|
|||||
|
2014
Q4 | $1.43M | Buy |
|
|||||
|
2014
Q3 | $1.18M | Sell |
|
|||||
|
2014
Q2 | $1.07M | Buy |
|
|||||
|
2014
Q1 | $793K | Sell |
|
|||||
|
2013
Q4 | $981K | Sell |
|
|||||
|
2013
Q3 | $1.89M | Buy |
|
|||||
|
2013
Q2 | $984K | Buy |
|